Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M. H. Otten"'
Autor:
E. Pecher, Brigitte Nault, R. E. Pruitt, M. H. Otten, David L. Earnest, K. ‐E. Langaker, W. J. Snape, Gervais Tougas, Mikhail Rojavin
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:1701-1708
Summary Background : Tegaserod is a 5-hydroxytryptamine-4 receptor partial agonist. Oral administration causes gastrointestinal effects resulting in increased gastrointestinal motility and attenuation of visceral sensation. Aim : To determine the lon
Publikováno v:
Alimentary Pharmacology and Therapeutics. 11:693-697
Background: 5-Aminosalicylic acid (5-ASA) is widely used as topical treatment in patients with distal inflammatory bowel disease. The enema spread and retention time are considered to be important factors in the efficacy of this therapeutic agent. Wh
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 147(50)
Lifestyle changes are recommended as the first step in the treatment of pregnant women with heartburn. If symptoms persist, antacids or the mucoprotective sucralfate can be prescribed. If symptoms are persistent and severe, acid secretion inhibitors
Autor:
A C, Poen, M H, Otten
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 147(34)
Although proton pump inhibitors and H2-receptor antagonists are usually prescribed for continuous use by patients with gastro-oesophageal reflux disease, at least 50% of such patients do not take their medication daily and some take it only sporadica
Autor:
G, Tougas, W J, Snape, M H, Otten, D L, Earnest, K-E, Langaker, R E, Pruitt, E, Pecher, B, Nault, M A, Rojavin
Publikováno v:
Alimentary pharmacologytherapeutics. 16(10)
Tegaserod is a 5-hydroxytryptamine-4 receptor partial agonist. Oral administration causes gastrointestinal effects resulting in increased gastrointestinal motility and attenuation of visceral sensation.: To determine the long-term safety and tolerabi
Autor:
G. H. De Groot, B. D. Westerveld, T. G. Tan, M. H. Otten, J. M. Smit, A. W.M. van Milligen de Wit, M. Oudkerk Pool, Chris J. J. Mulder
Publikováno v:
European journal of gastroenterologyhepatology. 14(6)
Proton pump inhibitors (PPIs) have proved to be effective in treating reflux oesophagitis. Until now, no study had compared the PPIs omeprazole Multiple Unit Pellet System (MUPS), lansoprazole and pantoprazole in patients with reflux oesophagitis.To
Autor:
C M, Gibson, M, Anshelevich, S, Murphy, L, Luu, C, Hynes, J, Kliris, S, Kermgard, M H, Otten, E M, Antman, C P, Cannon, E, Braunwald
Publikováno v:
The American journal of cardiology. 86(12)
The mechanical force of injection at 90 minutes opens 13.4% of occluded arteries, but overall, only 2.4% of all culprit arteries (already open and occluded combined) are opened. Thus, although some arteries are opened by the force of hand injection,
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 144(14)
The most important symptom in acute pancreatitis is pain. This pain often is so severe that treatment is started with opioid analgesics. In daily practice meperidine is often the analgesic of first choice because it is supposed to cause less spasm of
Autor:
M H, Otten
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 143(50)
Gastric acid stimulates the absorption of nutrients and is the most important non-immunological defence system against the constant bacterial invasion of our digestive tract. Patients with achlorhydria and resected stomachs have excessive growth of b
Publikováno v:
Alimentary pharmacologytherapeutics. 11(4)
5-aminosalicylic acid (5-ASA) is widely used as topical treatment in patients with distal inflammatory bowel disease. The enema spread and retention time are considered to be important factors in the efficacy of this therapeutic agent. Whereas coloni